<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(1)</volume><submitter>Chen X</submitter><funding>Program of Shanghai Academic Research Leader</funding><funding>National Natural Science Foundation of China</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><journal>Signal transduction and targeted therapy</journal><pagination>67</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9935627</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>circGLS2 inhibits hepatocellular carcinoma recurrence via regulating hsa-miR-222-3p-PTEN-AKT signaling.</pubmed_title><pmcid>PMC9935627</pmcid><funding_grant_id>81373067</funding_grant_id><pubmed_authors>Ma L</pubmed_authors><pubmed_authors>Tan X</pubmed_authors><pubmed_authors>Xian L</pubmed_authors><pubmed_authors>Cao G</pubmed_authors><pubmed_authors>Cai P</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Wu T</pubmed_authors><pubmed_authors>Li N</pubmed_authors><pubmed_authors>Liu W</pubmed_authors><pubmed_authors>Yin J</pubmed_authors></additional><is_claimable>false</is_claimable><name>circGLS2 inhibits hepatocellular carcinoma recurrence via regulating hsa-miR-222-3p-PTEN-AKT signaling.</name><description/><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-04T23:12:57.659Z</modification><creation>2025-04-04T23:12:57.659Z</creation></dates><accession>S-EPMC9935627</accession><cross_references><pubmed>36797228</pubmed><doi>10.1038/s41392-022-01275-6</doi></cross_references></HashMap>